Open AccessWorsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]
Author(s) -
Eric Nudleman,
Jeremy D. Wolfe,
Maria A. Woodward,
Yoshihiro Yonekawa,
George Williams,
T. Hassan
Publication year - 2017
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s133223
Subject(s) - aflibercept , macular degeneration , medicine , ranibizumab , ophthalmology , optometry , surgery , bevacizumab , chemotherapy
[This corrects the article on p. 1053 in vol. 10, PMID: 27354759.].
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom